Il Dong Kim1, Ho Sun Chang, Kyung Jin Hwang. 1. Department of Obstetrics and Gynecology, Grace Women's Hospital, 1334 Baekseok-dong, Ilsandong-gu, Goyang 410-360, Korea. kimid@hanmail.net
Abstract
PURPOSE: This study determined the seroprevalence of herpes virus 2 in gravidas and the differences between herpes virus 2-infected and healthy gravidas. The need to screen gravidas for herpes virus 2 was also evaluated. MATERIALS AND METHODS: A retrospective analysis involving 500 gravidas who underwent herpes virus 2 serologic testing and delivery in our hospital between January 2009 and August 2010 was performed. All patients in the study group were classified as herpes simplex virus 2 (HSV2) positive, and all cases were analyzed with respect to the clinical course of the pregnancy, pregnancy outcome, obstetric complications, and neonatal outcomes. SPSS software (version 14.0) was used for statistical analysis. A chi-square test and Student's t-test were used for statistical analysis. RESULTS: In the current study, the herpes virus 2 seroprevalence rate in gravidas was 17%. There was no significant difference in the rates of preterm delivery, premature rupture of membranes, preterm labor, and intrauterine growth restriction between the herpes virus 2-infected gravidas and the healthy control group. The rates of spontaneous abortion and sexually transmitted disease were higher in the herpes virus 2 infection group than the healthy control group. CONCLUSION: After educating gravidas on genital herpes and, if gravidas thereafter consent to herpes virus 2 screening, the risk of neonatal herpes virus 2 infections can be reduced. In addition, examination of gravidas for sexually transmitted diseases would increase as would appropriate treatment.
PURPOSE: This study determined the seroprevalence of herpes virus 2 in gravidas and the differences between herpes virus 2-infected and healthy gravidas. The need to screen gravidas for herpes virus 2 was also evaluated. MATERIALS AND METHODS: A retrospective analysis involving 500 gravidas who underwent herpes virus 2 serologic testing and delivery in our hospital between January 2009 and August 2010 was performed. All patients in the study group were classified as herpes simplex virus 2 (HSV2) positive, and all cases were analyzed with respect to the clinical course of the pregnancy, pregnancy outcome, obstetric complications, and neonatal outcomes. SPSS software (version 14.0) was used for statistical analysis. A chi-square test and Student's t-test were used for statistical analysis. RESULTS: In the current study, the herpes virus 2 seroprevalence rate in gravidas was 17%. There was no significant difference in the rates of preterm delivery, premature rupture of membranes, preterm labor, and intrauterine growth restriction between the herpes virus 2-infected gravidas and the healthy control group. The rates of spontaneous abortion and sexually transmitted disease were higher in the herpes virus 2 infection group than the healthy control group. CONCLUSION: After educating gravidas on genital herpes and, if gravidas thereafter consent to herpes virus 2 screening, the risk of neonatal herpes virus 2 infections can be reduced. In addition, examination of gravidas for sexually transmitted diseases would increase as would appropriate treatment.
Authors: D Heather Watts; Zane A Brown; Deborah Money; Stacy Selke; Meei Li Huang; Stephen L Sacks; Lawrence Corey Journal: Am J Obstet Gynecol Date: 2003-03 Impact factor: 8.661
Authors: Marshall W Munjoma; Edith N Kurewa; Munyaradzi P Mapingure; Grace V Mashavave; Mike Z Chirenje; Simbarashe Rusakaniko; Akhtar Hussain; Babill Stray-Pedersen Journal: BMC Womens Health Date: 2010-01-12 Impact factor: 2.809
Authors: V V Zverev; O V Makarov; A Z Khashukoeva; O A Svitich; Y E Dobrokhotova; E A Markova; P A Labginov; S A Khlinova; E A Shulenina; L V Gankovskaya Journal: Lasers Med Sci Date: 2016-03-22 Impact factor: 3.161
Authors: Cleine Aglacy Nunes Miranda; Erika Galvão Lima; Diego Breno Soares de Lima; Ricardo Ney Oliveira Cobucci; Maria da Conceição de Mesquita Cornetta; Thales Allyrio Araújo de Medeiros Fernandes; Paulo Roberto Medeiros de Azevedo; Jenner Chrystian Veríssimo de Azevedo; Josélio Maria Galvão de Araújo; José Veríssimo Fernandes Journal: ISRN Obstet Gynecol Date: 2014-03-11
Authors: Sevi Giakoumelou; Nick Wheelhouse; Kate Cuschieri; Gary Entrican; Sarah E M Howie; Andrew W Horne Journal: Hum Reprod Update Date: 2015-09-19 Impact factor: 15.610